Coronavirus crisis: Victorian and Tasmanian deaths linked to AstraZeneca

Callum GoddeAAP
Video[NFA] Australia's two largest states reported sharp increases in new COVID-19 cases on Wednesday, a blow to hopes that lockdown restrictions would be lifted with more than half the country's population under stay-at-home orders.

A 48-year-old Victorian woman has died from the blood clotting condition linked to the AstraZeneca coronavirus vaccine.

In its weekly safety report on Thursday, the Therapeutic Goods Administration says the 48-year-old suffered confirmed thrombocytopenia syndrome (TTS) and died after receiving her first dose.

A 44-year-old man from Tasmania suffered the same fate.

“We extend our sincere condolences to their families and loved ones,” the national medicines regulator says.

Only five confirmed TTS deaths have been reported in Australia from more than 6.1 million AstraZeneca doses. All are linked to people receiving their first dose.

Pfizer remains the recommended vaccine for Australians under 60 due to the extremely rare blood clotting condition linked to the AstraZeneca jab.

Get the latest news from in your inbox.

Sign up for our emails